📰 Development Highlights News
Page 4 - Development Highlights News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Highlights. Real-time updates on events, politics, business and more.
August 3, 2023
Tirupati Graphite production up 59%, revenues up 76%
May 16, 2023
Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress Halle (Saale) / Munich, Germany, May 16, 2023 - Vivoryon Therapeutics N.V. (Euronext
May 16, 2023
Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress Halle (Saale) / Munich, Germany, May 16, 2023 - Vivoryon Therapeutics N.V. (Euronext
May 12, 2023
Valeura Energy Inc. Announces Q1 2023 Results and Executive Leadership ...
May 1, 2023
JERSEY CITY, N.J., May 01, 2023 -- Vision Energy Corporation is pleased to provide a Corporate and Project Development Update. Vision Energy recently announced results for the fiscal year ended... | May 1, 2023
March 14, 2023
14.03.2023 - - Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 - Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and ...
February 1, 2023
IMPORTANCE OF SCIENTIFIC RESEARCH. Climate Change Commission vice chairperson and executive director Robert Borje (center) highlights the importance of scientific research and development in addressing climate change during the 34th Regional Symposium on Research and Development Highlights in Batac City, Ilocos Norte province on Wednesday (Feb. 1, 2023). Borje said local researchers' cooperation is vital in ensuring the successful implementation of climate change action plan in the country. ...
February 1, 2023
/PRNewswire/ -- HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines...
November 22, 2022
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): 9 Month figures Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational Progress (news with additional features) 22.11.2022 / 07:20 CET/CEST The issuer is solely responsible...
November 15, 2022
Financial results for Q3 2022 ended with revenue of KRW 29.6 billion with continued growth in the pharmaceutical division driven by product portfo...